电子封装材料

Search documents
德邦科技上半年净利润约4557万元,同比增加35.19%
Ju Chao Zi Xun· 2025-08-16 04:35
8月16日,德邦科技发布半年度业绩报告称,2025年上半年营业收入约6.9亿元,同比增加49.02%;归属 于上市公司股东的净利润约4557万元,同比增加35.19%;基本每股收益0.32元,同比增加33.33%。 德邦科技在2025年半年度报告中提到,报告期内其经营业务出现了较大变动,主要体现在以下几个方 面: 多年来,德邦科技凭借卓越的技术实力,成功将芯片固晶材料、晶圆 UV 膜等集成电路封装材料批量供 应给国内知名封测企业,包括了华天科技、通富微电、长电科技、日月新等全球知名封测厂商;智能终 端封装材料亦广泛应用于国内外知名品牌,包括苹果公司、华为公司、小米科技等智能终端领域的全球 龙头企业;同时,宁德时代、中创新航、比亚迪、通威股份、阿特斯等新能源领域的知名企业亦成为公 司的合作伙伴,这些优质客户资源为公司的发展提供了强有力的支撑。 首先,公司在集成电路封装材料领域取得了显著进展,得益于市场环境的整体向好及客户需求的持续增 长。各业务板块均实现了稳定增长,其中原有业务贡献了约40.77%的收入增长,而通过对泰吉诺的并 购,公司在营业收入上贡献了约8.25%。 其次,智能终端封装材料的市场渗透率进一步提 ...
德邦科技丰富产品矩阵 上半年净利润同比增长35.19%
Zheng Quan Ri Bao Zhi Sheng· 2025-08-16 04:09
从行业表现来看,随着集成电路、智能终端、新能源等产业快速发展,对相关封装材料需求持续增长。 德邦科技持续加大研发投入,上半年研发投入3777.35万元,同比增长43.25%,研发费用占营业收入比 例为5.47%。 在研发成果转化上,公司多个项目取得突破。如COF倒装薄膜底填胶通过国内头部客户验证,满足显示 驱动IC封装需求;自主研发的手机曲面屏密封粘接用单组分湿气固化聚氨酯热熔胶实现量产应用,已应 用于国内头部手机制造商多款高端机型;新能源动力电池用MS杂化树脂材料实现产品扩展,成功在国 内头部新能源汽车厂商多款车型上批量使用等。 (编辑 张伟) 本报讯 (记者王僖)8月15日晚,烟台德邦科技股份有限公司(以下简称"德邦科技")发布2025年半年 度报告,公司上半年实现营业收入6.9亿元,同比大幅增长49.02%;归属于上市公司股东的净利润达 4557.35万元,同比增长35.19%。公司拟向全体股东每10股派发现金红利1.00元(含税)。 德邦科技上半年业绩增长主要源于两方面。一方面,报告期内公司产品系列不断丰富,新的应用点持续 突破,所处市场环境整体向好,有力推动了营业收入大幅增长。公司以集成电路封装材料 ...
德邦科技:8月15日召开董事会会议
Mei Ri Jing Ji Xin Wen· 2025-08-15 12:10
(文章来源:每日经济新闻) 德邦科技(SH 688035,收盘价:49.05元)8月15日晚间发布公告称,公司第二届第十九次董事会会议 于2025年8月15日以现场结合通讯表决的方式召开。会议审议了《关于及摘要的议案》等文件。 2024年1至12月份,德邦科技的营业收入构成为:电子封装材料占比99.85%,其他业务占比0.15%。 ...
【港股IPO】6月9日-6月10日,港交所IPO动态,5家企业通过聆讯、2家企业递表
Sou Hu Cai Jing· 2025-06-10 11:20
Group 1: IPO Approvals - Five companies have successfully passed the IPO hearing on June 9-10, including Yaojie Ankang, Yingtong Holdings, Saint Bella, Xiangjiang Electric, and Cao Cao Mobility [1] - Two companies, Guangzhou Yinnuo Pharmaceutical Group and Shenzhen Chuangzhixin Lian Technology, have submitted their IPO applications [12][13] Group 2: Yaojie Ankang - Yaojie Ankang is a biopharmaceutical company focused on developing innovative therapies for tumors, inflammation, and cardiovascular metabolic diseases [1] - The company's core product, Tinengotinib, is a multi-target kinase inhibitor currently undergoing two pivotal clinical trials for cholangiocarcinoma [2] Group 3: Yingtong Holdings - Yingtong Holdings is the largest perfume group in China (including Hong Kong and Macau) excluding brand owners [3] - The company operates a comprehensive sales and distribution network across over 400 cities in China, leveraging both offline and online channels [4] Group 4: Saint Bella - Saint Bella is a leading postpartum care and recovery group in China, aiming to become a comprehensive family care brand in Asia [6] - The company is recognized as the largest postpartum care group in Asia based on revenue from maternity centers [7] Group 5: Xiangjiang Electric - Xiangjiang Electric is a manufacturer of household appliances in China, primarily operating under ODM/OEM models [8] - The company ranks as the tenth largest in the kitchen small appliances sector in China, with a market share of 0.8% [8] Group 6: Cao Cao Mobility - Cao Cao Mobility is a ride-hailing platform incubated by Geely Group, operating in 136 cities as of December 31, 2024 [10] - The company's total gross transaction value (GTV) reached RMB 12.2 billion in 2023, reflecting a 37.5% increase from 2022 [10] Group 7: Guangzhou Yinnuo Pharmaceutical - Guangzhou Yinnuo Pharmaceutical focuses on developing therapies for diabetes and metabolic diseases, with a core product targeting type 2 diabetes [12] - The company has a pipeline that includes several candidates in clinical and preclinical stages [12] Group 8: Shenzhen Chuangzhixin Lian Technology - Shenzhen Chuangzhixin Lian is a leading provider of metallization interconnect plating materials and key process technologies in China [13] - The company is recognized as the largest domestic supplier of wet process plating materials in the Chinese market [13]